Dihydrolipoamide Dehydrogenase/DLD Antibody, Novus Biologicals™

Dihydrolipoamide Dehydrogenase/DLD

Polyclonal

Unconjugated

PBS (pH 7.0), 1.0% BSA and 20% Glycerol with 0.01% Thimerosal

DLD

Recombinant protein encompassing a sequence within the center region of human DLD. The exact sequence is proprietary.

Protein A purified

RUO

1738

Human, Mouse, Rat

Purified

Western Blot, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin)

5.8mg/mL

Western Blot 1:500-1:3000, Immunohistochemistry 1:100-1:1000, Immunocytochemistry/Immunofluorescence 1:100-1:1000, Immunohistochemistry-Paraffin 1:100-1:1000

2-oxo-glutarate complex, branched chain keto acid dehydrogenase complex), branched chain keto acid dehydrogenase complex, dihydrolipoamide dehydrogenase (E3 component of pyruvate dehydrogenase complex, dihydrolipoamide dehydrogenasemitochondrial, DLDH, E3, E3 component of pyruvate dehydrogenase complex, 2-oxo-glutarate complex, EC 1.8.1, EC 1.8.1.4, GCSL, Glycine cleavage system L protein, glycine cleavage system protein L, lipoamide dehydrogenase, lipoamide reductase, lipoyl dehydrogenase

Rabbit

54 kDa

0.1 mL

Primary

Tested in human. Predicted cross-reactivity based on sequence identity:Xenopus laevis(94%). Not yet tested in any other species.

Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.

IgG